tetano
Editor, Senior Moderator
Clin Microbiol Infect. 2014 Jun 7. doi: 10.1111/1469-0691.12708. [Epub ahead of print]
Should we recommend neuroaminidase inhibitors for influenza?
Leibovici L1, Paul M.
Author information
Abstract
A recent Cochrane systematic review shook the base of evidence on neuraminidase inhibitors (NIs) claiming that NIs have negligible efficacy in the treatment of influenza1 . An individual patient data meta-analysis seemingly contradicts these findings2 . The public, physicians, policy makers and governments are now struggling to understand how to translate these findings to clinical practice. This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.
PMID:
24909297
[PubMed - as supplied by publisher]
http://www.ncbi.nlm.nih.gov/pubmed/24909297
Should we recommend neuroaminidase inhibitors for influenza?
Leibovici L1, Paul M.
Author information
Abstract
A recent Cochrane systematic review shook the base of evidence on neuraminidase inhibitors (NIs) claiming that NIs have negligible efficacy in the treatment of influenza1 . An individual patient data meta-analysis seemingly contradicts these findings2 . The public, physicians, policy makers and governments are now struggling to understand how to translate these findings to clinical practice. This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.
PMID:
24909297
[PubMed - as supplied by publisher]
http://www.ncbi.nlm.nih.gov/pubmed/24909297